Common Contracts

Confidential Treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are designated as “***”. A complete version of this exhibit has been filed...

License and Development Agreement • November 14th, 2007 • Novadel Pharma Inc • Pharmaceutical preparations • New Jersey

• Contract Type
  License and Development Agreement
• Filed
  November 14th, 2007
• Company
  Novadel Pharma Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New Jersey

THIS AMENDED AND RESTATED LICENSE AND DEVELOPMENT AGREEMENT (this “Agreement”), dated as of July 31, 2007 (the “Execution Date”), is entered into by and between NOVADEL PHARMA, INC., a Delaware corporation (“NovaDel”), and HANA BIOSCIENCES, INC., a Delaware corporation (the “Licensee”). NovaDel and Licensee each may be referred to herein individually as a “Party,” or collectively as the “Parties.”

INFORMATION MARKED BY [***] HAS BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED PORTION HAS BEEN SEPARATELY FILED WITH THE SECURITIES AND EXCHANGE COMMISSION. AMENDED AND RESTATED LICENSE AND DEVELOPMENT AGREEMENT

License and Development Agreement • November 8th, 2007 • Hana Biosciences Inc • Pharmaceutical preparations • New Jersey

• Contract Type
  License and Development Agreement
• Filed
  November 8th, 2007
• Company
  Hana Biosciences Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New Jersey

THIS AMENDED AND RESTATED LICENSE AND DEVELOPMENT AGREEMENT (this “Agreement”), dated as of July 31, 2007 (the “Execution Date”), is entered into by and between NovaDel Pharma, Inc., a Delaware corporation (“NovaDel”), and Hana Biosciences, Inc., a Delaware corporation (the “Licensee”). NovaDel and Licensee each may be referred to herein individually as a “Party,” or collectively as the “Parties.”